CAD 0.23
(2.22%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -711.00 CAD | 50.0% |
2022 | -1422.00 CAD | 19.98% |
2021 | -1777.00 CAD | -400.56% |
2020 | -355.00 CAD | 0.0% |
2019 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - CAD | 0.0% |
2023 Q2 | -356.00 CAD | -0.28% |
2023 Q4 | - CAD | 0.0% |
2023 Q3 | - CAD | 100.0% |
2023 Q1 | -355.00 CAD | 0.28% |
2022 Q3 | -355.00 CAD | 0.28% |
2022 FY | -1422.00 CAD | 19.98% |
2022 Q4 | -356.00 CAD | -0.28% |
2022 Q2 | -356.00 CAD | -0.28% |
2022 Q1 | -355.00 CAD | 50.07% |
2021 Q4 | -711.00 CAD | -100.28% |
2021 FY | -1777.00 CAD | -400.56% |
2021 Q3 | -355.00 CAD | 0.28% |
2021 Q2 | -356.00 CAD | -0.28% |
2021 Q1 | -355.00 CAD | -100.56% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | -355.00 CAD | 0.0% |
2020 Q4 | -177.00 CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 98.589% |
Asep Medical Holdings Inc | -113.74 Thousand CAD | 99.375% |
BetterLife Pharma Inc. | - CAD | Infinity% |
BioVaxys Technology Corp. | - CAD | Infinity% |
ChitogenX Inc. | -42 Thousand CAD | 98.307% |
Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 100.126% |
Defence Therapeutics Inc. | -90.92 Thousand CAD | 99.218% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 100.284% |
Gemina Laboratories Ltd. | -93.36 Thousand CAD | 99.238% |
Glow Lifetech Corp. | -505.62 Thousand CAD | 99.859% |
Lexston Life Sciences Corp. | -26.39 Thousand CAD | 97.306% |
Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 100.157% |
Doseology Sciences Inc. | -36.08 Thousand CAD | 98.03% |
MYND Life Sciences Inc. | -332.99 Thousand CAD | 99.786% |
Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 102.799% |
PreveCeutical Medical Inc. | -9856.00 CAD | 92.786% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 100.119% |